Spectrum Management Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $4.16M | Buy |
30,991
+228
| +0.7% | +$32.7K | 0.9% | 34 |
|
|
2022
Q2 | $4.71M | Buy |
30,763
+23,883
| +347% | +$3.65M | 1.11% | 30 |
|
|
2022
Q1 | $1.11M | Hold |
6,880
| – | – | 0.18% | 82 |
|
|
2021
Q4 | $932K | Sell |
6,880
-395
| -5% | -$46.7K | 0.13% | 90 |
|
|
2021
Q3 | $785K | Buy |
7,275
+303
| +4% | +$34.6K | 0.12% | 86 |
|
|
2021
Q2 | $785K | Hold |
6,972
| – | – | 0.14% | 89 |
|
|
2021
Q1 | $755K | Hold |
6,972
| – | – | 0.15% | 84 |
|
|
2020
Q4 | $747K | Hold |
6,972
| – | – | 0.16% | 84 |
|
|
2020
Q3 | $611K | Sell |
6,972
-48,250
| -87% | -$4.54M | 0.14% | 85 |
|
|
2020
Q2 | $5.42M | Buy |
55,222
+48,300
| +698% | +$4.25M | 1.38% | 17 |
|
|
2020
Q1 | $527K | Buy |
6,922
+4,345
| +169% | +$370K | 0.18% | 72 |
|
|
2019
Q4 | $228K | Hold |
2,577
| – | – | 0.09% | 92 |
|
|
2019
Q3 | $195K | Hold |
2,577
| – | – | 0.07% | 90 |
|
|
2019
Q2 | $187K | Hold |
2,577
| – | – | 0.05% | 99 |
|
|
2019
Q1 | $208K | Sell |
2,577
-310
| -11% | -$25.4K | 0.06% | 81 |
|
|
2018
Q4 | $266K | Hold |
2,887
| – | – | 0.09% | 68 |
|
|
2018
Q3 | $273K | Sell |
2,887
-28,595
| -91% | -$2.71M | 0.09% | 73 |
|
|
2018
Q2 | $2.92M | Buy |
31,482
+930
| +3% | +$90.8K | 1.01% | 23 |
|
|
2018
Q1 | $2.89M | Buy |
30,552
+700
| +2% | +$76.9K | 1.05% | 17 |
|
|
2017
Q4 | $2.89M | Sell |
29,852
-2,790
| -9% | -$263K | 1% | 17 |
|
|
2017
Q3 | $2.9M | Buy |
32,642
+4,542
| +16% | +$346K | 0.94% | 16 |
|
|
2017
Q2 | $2.04M | Buy |
28,100
+2,892
| +11% | +$194K | 0.77% | 16 |
|
|
2017
Q1 | $1.64M | Buy |
25,208
+245
| +1% | +$15.4K | 0.6% | 20 |
|
|
2016
Q4 | $1.56M | Buy |
24,963
+3,060
| +14% | +$187K | 0.57% | 23 |
|
|
2016
Q3 | $1.38M | Buy |
+21,903
| New | +$1.42M | 0.56% | 19 |
|
|
2016
Q2 | – | Sell |
-978
| Closed | -$56K | – | 89 |
|
|
2016
Q1 | $56K | Sell |
978
-1,225
| -56% | -$68.3K | 0.02% | 127 |
|
|
2015
Q4 | $131K | Buy |
2,203
+1,453
| +194% | +$83.7K | 0.05% | 78 |
|
|
2015
Q3 | $41K | Hold |
750
| – | – | 0.02% | 96 |
|
|
2015
Q2 | $50K | Hold |
750
| – | – | 0.02% | 58 |
|
|
2015
Q1 | $44K | Buy |
+750
| New | +$45.3K | 0.02% | 55 |
|
|
2014
Q4 | – | Sell |
-750
| Closed | -$43K | – | 132 |
|
|
2014
Q3 | $43K | Hold |
750
| – | – | 0.03% | 64 |
|
|
2014
Q2 | $42K | Hold |
750
| – | – | 0.03% | 66 |
|
|
2014
Q1 | $39K | Hold |
750
| – | – | 0.03% | 67 |
|
|
2013
Q4 | $40K | Buy |
+750
| New | +$36.9K | 0.03% | 67 |
|
Other funds holding ABBV
Spectrum Management Group's ABBV Position: Q3 2022 in Review
Spectrum Management Group increased its AbbVie (ABBV) stake by 0.74% in Q3 2022, buying an estimated $32.7K and bringing the position to 30,991 shares worth $4.16M. The position accounts for 0.9% of the portfolio, ranked #34.
Spectrum Management Group first reported a position in ABBV in Q4 2013 and has held it in 34 quarters since. The position peaked at $5.42M in Q2 2020. 2,968 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.
- Spectrum Management Group held 30,991 shares of AbbVie worth $4.16M as of Q3 2022.
- Spectrum Management Group bought 228 AbbVie shares in Q3 2022, an estimated $32.7K.
- AbbVie made up 0.9% of Spectrum Management Group's portfolio in Q3 2022, its #34 holding.
- Spectrum Management Group first reported a position in AbbVie in Q4 2013 and has held it in 34 quarters since.
- Spectrum Management Group's AbbVie position peaked at $5.42M in Q2 2020.
- 2,968 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.
Based on Spectrum Management Group's 13F filing for Q3 2022, filed 1 Nov 2022.